Should I buy or sell ZimVie stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" ZIMV shares. View ZIMV analyst ratings or view top-rated stocks .

What is ZimVie's stock price target for 2024?

3 analysts have issued 12-month target prices for ZimVie's shares. Their ZIMV share price targets range from $16.00 to $16.00. On average, they expect the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price. View analysts price targets for ZIMV or view top-rated stocks among Wall Street analysts .

How have ZIMV shares performed in 2024?

ZimVie's stock was trading at $17.75 at the start of the year. Since then, ZIMV shares have decreased by 13.1% and is now trading at $15.43. View the best growth stocks for 2024 here .

Are investors shorting ZimVie?

ZimVie saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 788,400 shares, an increase of 21.9% from the March 15th total of 647,000 shares. Based on an average trading volume of 370,300 shares, the days-to-cover ratio is currently 2.1 days. Approximately 3.0% of the company's shares are short sold. View ZimVie's Short Interest .

When is ZimVie's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our ZIMV earnings forecast .

How were ZimVie's earnings last quarter?

ZimVie Inc. (NASDAQ:ZIMV) announced its earnings results on Wednesday, February, 28th. The company reported $0.10 EPS for the quarter. The company had revenue of $113.07 million for the quarter. ZimVie had a positive trailing twelve-month return on equity of 2.44% and a negative net margin of 51.33%.

What ETF holds ZimVie's stock?

Invesco Russell 2000 Dynamic Multifactor ETF holds 79,950 shares of ZIMV stock, representing 0.36% of its portfolio.

What guidance has ZimVie issued on next quarter's earnings?

ZimVie updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $115.0 million-$118.0 million.

How do I buy shares of ZimVie?

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free ZIMV Stock Alerts

$15.43

-0.25 (-1.59%)

(As of 04/19/2024 ET)

Compare

Today's Range: $15.23
▼
$15.80
50-Day Range: $15.33
▼
$20.69
52-Week Range: $6.52
▼
$20.91

Volume: 178,793 shs
Average Volume: 358,171 shs
Market Capitalization: $420.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.00

Get ZimVie alerts:

ZimVie MarketRank™ Stock Analysis

Analyst Rating: Reduce
1.67 Rating Score
Upside/Downside: 3.7% Upside
$16.00 Price Target
Short Interest: Healthy
3.01% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.48
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.11 out of 5 stars

Medical Sector

892nd out of 911 stocks

Dental Equipment & Supplies Industry

3rd out of 3 stocks

0.8

Analyst's Opinion

Consensus Rating
ZimVie has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
ZimVie has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.01% of the float of ZimVie has been sold short.
Short Interest Ratio / Days to Cover
ZimVie has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in ZimVie has recently increased by 21.85%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
ZimVie does not currently pay a dividend.
Dividend Growth
ZimVie does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ZIMV.

1.4

News and Social Media Coverage

News Sentiment
ZimVie has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for ZimVie this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for ZIMV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added ZimVie to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ZimVie insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.01% of the stock of ZimVie is held by insiders.
Percentage Held by Institutions
95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of ZimVie is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ZimVie is -1.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ZimVie has a P/B Ratio of 1.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About ZimVie Stock (NASDAQ:ZIMV)

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZIMV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ZIMV Stock News Headlines

April 13, 2024 | americanbankingnews.com

ZimVie (NASDAQ:ZIMV) Stock Rating Reaffirmed by Needham & Company LLC

April 13, 2024 | americanbankingnews.com

ZimVie Inc. (NASDAQ:ZIMV) Sees Large Increase in Short Interest

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 1, 2024 | bizjournals.com

Public company sells spine business to H.I.G. Capital for $375 million

April 1, 2024 | finance.yahoo.com

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

April 1, 2024 | marketwatch.com

ZimVie Shares Rise 9% After Closing of Spine Business Sale for $375M

April 1, 2024 | globenewswire.com

ZimVie Announces Closing of Sale of Spine Business

March 27, 2024 | globenewswire.com

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

March 15, 2024 | finance.yahoo.com

Multiple Reasons for the Surge of ZimVie (ZIMV) in Q4

March 3, 2024 | finance.yahoo.com

One ZimVie Inc. (NASDAQ:ZIMV) Analyst Just Cut Their EPS Forecasts

March 1, 2024 | finanznachrichten.de

ZimVie Inc.: ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results

March 1, 2024 | seekingalpha.com

ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript

March 1, 2024 | finance.yahoo.com

ZimVie Full Year 2023 Earnings: EPS Misses Expectations

February 29, 2024 | finance.yahoo.com

Q4 2023 ZimVie Inc Earnings Call

February 29, 2024 | finance.yahoo.com

ZimVie Inc. (NASDAQ:ZIMV) Q4 2023 Earnings Call Transcript

February 28, 2024 | benzinga.com

Recap: ZimVie Q4 Earnings

February 28, 2024 | fool.com

ZimVie (ZIMV) Q4 2023 Earnings Call Transcript

February 28, 2024 | finance.yahoo.com

ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024 | finance.yahoo.com

ZimVie Inc (ZIMV) Navigates Market Challenges with Strategic Focus on Dental Segment

February 27, 2024 | markets.businessinsider.com

What Wall Street expects from ZimVie's earnings

February 22, 2024 | msn.com

Japan dental implants to reach $230m in 2033

February 21, 2024 | finance.yahoo.com

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

February 21, 2024 | globenewswire.com

ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

February 18, 2024 | finance.yahoo.com

ZIMV Mar 2024 15.000 put

February 18, 2024 | finance.yahoo.com

ZIMV Apr 2024 10.000 call

February 18, 2024 | finance.yahoo.com

ZIMV Mar 2024 15.000 call

See More Headlines

Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Dental equipment & supplies
Sub-Industry: N/A
Current Symbol: NASDAQ:ZIMV
CUSIP: N/A
CIK: 1876588
Web: www.zimvie.com
Phone: 303-443-7500
Fax: N/A
Employees: 2,600
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $16.00
High Stock Price Target: $16.00
Low Stock Price Target: $16.00
Potential Upside/Downside: +3.7%
Consensus Rating: Reduce
Rating Score (0-4): 1.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($14.81)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-393,280,000.00
Net Margins: -51.33%
Pretax Margin: -11.12%
Return on Equity: 2.44%
Return on Assets: 1.08%

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 2.78
Quick Ratio: 2.32

Sales & Book Value

Annual Sales: $457.43 million
Price / Sales: 0.92
Cash Flow: $4.84 per share
Price / Cash Flow: 3.19
Book Value: $15.43 per share
Price / Book: 1.00

Miscellaneous

Outstanding Shares: 27,220,000
Free Float: 26,402,000
Market Cap: $420.00 million
Optionable: Optionable
Beta: 2.18

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Vafa Jamali (Age 53)
President, CEO & Director
Comp: $1.41M
Mr. Richard J. Heppenstall (Age 53)
Executive VP, CFO & Treasurer
Comp: $749.83k
Mr. Indraneel Kanaglekar (Age 46)
Senior VP & President of Global Dental
Comp: $534.5k
Ms. Rebecca A. Whitney (Age 47)
Senior VP & President of Global Spine
Comp: $622.97k
Sandra Schneider
Chief Accounting Officer
Mr. Steve Rondeau
Senior VP & Chief Information Officer
Ms. Heather Kidwell (Age 55)
Senior VP, Chief Legal, HR & Compliance Officer and Corporate Secretary
Comp: $460.18k
Ms. Laura Driscoll
Vice President of Communications
Ms. Ann Vu
Senior Vice President of Regulatory Affairs, Quality Assurance & Clinical

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ZIMV Stock Analysis - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" ZIMV shares.
View ZIMV analyst ratings or view top-rated stocks.
What is ZimVie's stock price target for 2024?: 3 analysts have issued 12-month target prices for ZimVie's shares. Their ZIMV share price targets range from $16.00 to $16.00. On average, they expect the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price.
View analysts price targets for ZIMV or view top-rated stocks among Wall Street analysts.
How have ZIMV shares performed in 2024?: ZimVie's stock was trading at $17.75 at the start of the year. Since then, ZIMV shares have decreased by 13.1% and is now trading at $15.43.
View the best growth stocks for 2024 here.
Are investors shorting ZimVie?: ZimVie saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 788,400 shares, an increase of 21.9% from the March 15th total of 647,000 shares. Based on an average trading volume of 370,300 shares, the days-to-cover ratio is currently 2.1 days. Approximately 3.0% of the company's shares are short sold.
View ZimVie's Short Interest.
When is ZimVie's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ZIMV earnings forecast.

How were ZimVie's earnings last quarter?: ZimVie Inc. (NASDAQ:ZIMV) announced its earnings results on Wednesday, February, 28th. The company reported $0.10 EPS for the quarter. The company had revenue of $113.07 million for the quarter. ZimVie had a positive trailing twelve-month return on equity of 2.44% and a negative net margin of 51.33%.
What ETF holds ZimVie's stock?: Invesco Russell 2000 Dynamic Multifactor ETF holds 79,950 shares of ZIMV stock, representing 0.36% of its portfolio.
What guidance has ZimVie issued on next quarter's earnings?: ZimVie updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $115.0 million-$118.0 million.
How do I buy shares of ZimVie?: Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ZIMV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About ZimVie Stock (NASDAQ:ZIMV)

ZIMV Stock Price History

ZIMV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

ZIMV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™